Skip to main content
. 2016 Nov 3;11:145. doi: 10.1186/s13023-016-0530-z

Table 1.

Patient’s characteristics

Patients Gender Mutation CNS Manifestations Age Epilepsy Onset Duration of epilepsy prior to Everolimus Antiepileptic drug therapy at baseline VNS KD Prior Epilepsy Surgery Prior SEGA Surgery Age Everolimus Start
1 m TSC1 SEGA, SEN, RML 4 years 2 years TPM 6 years
2 m TSC2 SEGA, SEN, RML 3 months 16 years 9 months OXC 17 years 3 mths
3 f TSC2 SEGA, SEN, RML 9 months 12 years 3 months VPA, LEV, PHT 12 years 10 mths
4 f TSC2 SEGA, SEN 6 months 5 years 6 months LEV y 6 years 2 mths
5 f TSC2 SEGA, SEN 7 months 16 years 6 months LEV, PGB y 17 years 1 mths
6 m TSC2 SEGA, SEN 3 months 6 years 9 months RUF, ZNS y 6 years 11 mths
7 f TSC1 SEGA, SEN 2 years 9 months 16 years 3 months OXC 18 years 6 mths
8 m TSC2 SEGA, SEN 3 months 1 year 9 months TPM, LEV, VGB 2 years 1 mths
9 m TSC2 SEGA, SEN 2 years 4 years VGB 6 years 8 mths
10 m TSC1 SEGA, SEN, RML 4 months 14 years 9 months OXC, PGB y 15 years 6 mths
11 f TSC1 SEGA, SEN, RML 2 years 2 years OXC, VGB y 3 years 11 mths
12 m TSC2 SEGA, SEN 1 year 3 months 5 years RUF y 8 years 1 mths
13 m TSC2 SEGA, SEN, RML 4 months 5 years 9 months VPA 6 years 8 mths
14 m TSC2 SEGA, SEN 4 months 0 year 9 months VGB, LEV y 1 year
15 f negative SEGA, SEN 1 year 3 months 2 years RUF, TPM 3 years 3 mths